+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiac Tissue Engineering Market by Product Type, Application, Technology, End User, Cell Source - Global Forecast to 2030- Product Image
Cardiac Tissue Engineering Market by Product Type, Application, Technology, End User, Cell Source - Global Forecast to 2030- Product Image
Sale

Cardiac Tissue Engineering Market by Product Type, Application, Technology, End User, Cell Source - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6014766
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cardiac tissue engineering market is entering a dynamic phase defined by rapid scientific advances, shifting regulatory perspectives, and evolving global trade conditions. For senior decision-makers navigating regenerative medicine investments, understanding the multi-faceted growth drivers, challenges, and competitive environment is essential to informed strategy.

Market Snapshot: Cardiac Tissue Engineering Market

The cardiac tissue engineering market grew from USD 10.45 billion in 2024 to USD 11.37 billion in 2025, sustaining an expected CAGR of 8.62% through 2030 and reaching USD 17.18 billion at forecast maturity. This robust expansion reflects sustained investment in clinical translation, technological innovation, and the scaling of novel cardiac regenerative solutions. Emerging reimbursement models and regulatory clarity continue to influence capital flows and accelerate product adoption for targeted cardiac repair.

Scope & Segmentation

This analysis provides a comprehensive perspective on core market segments, enabling stakeholders to identify opportunity areas and competitive positioning. Segmentation encompasses product types, clinical applications, technologies, end-user categories, and cell source strategies. Key geographic regions are evaluated for their role in shaping demand and commercial pathways.

  • Product Types: Bioartificial hearts (partial and whole), cardiac patches (decellularized, electrospun), cardiac scaffolds (biological, synthetic), and injectable hydrogels (natural, synthetic).
  • Applications: Heart valve regeneration (biological, mechanical), myocardial repair (congenital defect, post-infarction), and vascular grafting (coronary artery bypass, peripheral vascular repair).
  • Technologies: 3D bioprinting (extrusion, inkjet, laser-assisted); decellularized matrices (tissue segment, whole organ); stem cell therapies (embryonic, induced pluripotent, mesenchymal).
  • End Users: Biotechnology firms, hospitals, pharmaceutical companies, and research institutes are all engaged from R&D to clinical and commercial deployment.
  • Cell Sources: Allogeneic (donor cardiomyocytes, stromal cells), autologous (patient-derived cardiomyocytes, stromal cells), and xenogeneic (bovine, porcine) materials supporting product innovation and regulatory complexity management.
  • Regions: Detailed market insights are delivered for the Americas (U.S., Canada, Mexico, Brazil, Argentina), Europe, Middle East, and Africa (highlighting both EU harmonization and regional export hubs), and Asia-Pacific (China, India, Japan, Southeast Asia, Australia, Korea, and more).
  • Company Developments: Leading players include Organovo Holdings, Tara Biosystems, InSphero AG, Ncardia B.V., NovoHeart, BioCardia, BICO Group, Matricelf, XylyxBio, and AxoSim, each contributing innovations to the value chain.

Key Takeaways for Senior Decision-Makers

  • Breakthroughs such as high-resolution 3D bioprinting and next-generation decellularization are shortening time-to-market for functional cardiac constructs.
  • Collaboration models uniting biotechs, hospitals, and academic research are accelerating protocol standardization and process scale-up, creating efficiencies along the clinical-commercial interface.
  • The rise of real-world evidence and economic modeling supports value-based adoption, aligning with payer priorities and healthcare system requirements.
  • Segment diversification—through modular biofabrication, scaffold design optimization, and tailored cell therapies—continues to differentiate providers and drive competitive advantage.
  • Geographic variation influences market access; the United States leads with R&D funding and clinical trial counts, while Asia-Pacific is driving cost-effective innovations tailored to rapidly expanding patient populations.
  • Cell sourcing strategies directly affect regulatory approval pathways, product availability, and scaling dynamics, shaping go-to-market planning across regions.

Tariff Policy Dynamics: Navigating Supply Chain Challenges

U.S. tariffs introduced in 2025 have affected cost structures for cardiac tissue engineering stakeholders, especially those reliant on imported biomaterials and specialized reagents. In response, many companies are investing in domestic sourcing and regional manufacturing processes. Others are leveraging tariff pressures to pursue vertical integration or locate production in favorable trade zones. These adaptive measures help maintain quality standards, manage cost risk, and inform future geographic expansion strategies.

Methodology & Data Sources

This report applies a rigorous methodology, triangulating primary interviews with industry experts, clinicians, and executives, along with thorough review of peer-reviewed literature, regulatory filings, and market analytics. Financial data, clinical trial registries, and insights from government and trade associations underpin segmentation validation and ensure data reliability.

Why This Report Matters

  • Enables strategic planning with actionable insights into segment opportunities, technology adoption, and regional growth levers.
  • Supports risk mitigation and investment prioritization through real-world analysis of tariff impacts, supply chain shifts, and collaboration models.
  • Informs stakeholder dialogue, from R&D planning to market access strategy, by providing an integrated, evidence-driven perspective on sector developments.

Conclusion

The cardiac tissue engineering market is evolving quickly as technological advances and collaborative ecosystems align to address critical unmet healthcare needs. Senior decision-makers armed with targeted insights can accelerate innovation, capitalize on emerging geographies, and shape the future of cardiac regenerative medicine.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cardiac Tissue Engineering Market, by Product Type
8.1. Introduction
8.2. Bioartificial Hearts
8.2.1. Partial Hearts
8.2.2. Whole Hearts
8.3. Cardiac Patches
8.3.1. Decellularized Patches
8.3.2. Electrospun Patches
8.4. Cardiac Scaffolds
8.4.1. Biological Scaffolds
8.4.2. Synthetic Scaffolds
8.5. Injectable Hydrogels
8.5.1. Natural Hydrogels
8.5.2. Synthetic Hydrogels
9. Cardiac Tissue Engineering Market, by Application
9.1. Introduction
9.2. Heart Valve Regeneration
9.2.1. Biological Valve Regeneration
9.2.2. Mechanical Valve Replacement
9.3. Myocardial Repair
9.3.1. Congenital Defect Repair
9.3.2. Post Infarction Repair
9.4. Vascular Grafting
9.4.1. Coronary Artery Bypass
9.4.2. Peripheral Vascular Repair
10. Cardiac Tissue Engineering Market, by Technology
10.1. Introduction
10.2. 3D Bioprinting
10.2.1. Extrusion Based
10.2.2. Inkjet Based
10.2.3. Laser Assisted
10.3. Decellularized Matrices
10.3.1. Tissue Segment Decellularization
10.3.2. Whole Organ Decellularization
10.4. Stem Cell Therapy
10.4.1. Embryonic Stem Cells
10.4.2. Induced Pluripotent Stem Cells
10.4.3. Mesenchymal Stem Cells
11. Cardiac Tissue Engineering Market, by End User
11.1. Introduction
11.2. Biotechnology Companies
11.3. Hospitals
11.4. Pharmaceutical Companies
11.5. Research Institutes
12. Cardiac Tissue Engineering Market, by Cell Source
12.1. Introduction
12.2. Allogeneic
12.2.1. Donor Cardiomyocytes
12.2.2. Donor Stromal Cells
12.3. Autologous
12.3.1. Cardiomyocytes
12.3.2. Stromal Cells
12.4. Xenogeneic
12.4.1. Bovine Cells
12.4.2. Porcine Cells
13. Americas Cardiac Tissue Engineering Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cardiac Tissue Engineering Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cardiac Tissue Engineering Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Organovo Holdings, Inc.
16.3.2. Tara Biosystems, Inc.
16.3.3. InSphero AG
16.3.4. Ncardia B.V.
16.3.5. NovoHeart, Inc.
16.3.6. BioCardia, Inc.
16.3.7. BICO Group AB
16.3.8. Matricelf, Inc.
16.3.9. XylyxBio LLC
16.3.10. AxoSim, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CARDIAC TISSUE ENGINEERING MARKET MULTI-CURRENCY
FIGURE 2. CARDIAC TISSUE ENGINEERING MARKET MULTI-LANGUAGE
FIGURE 3. CARDIAC TISSUE ENGINEERING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CARDIAC TISSUE ENGINEERING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CARDIAC TISSUE ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CARDIAC TISSUE ENGINEERING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PARTIAL HEARTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY WHOLE HEARTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ELECTROSPUN PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOLOGICAL SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOLOGICAL VALVE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MECHANICAL VALVE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CONGENITAL DEFECT REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY POST INFARCTION REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CORONARY ARTERY BYPASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PERIPHERAL VASCULAR REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY EXTRUSION BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INKJET BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY LASER ASSISTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TISSUE SEGMENT DECELLULARIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY WHOLE ORGAN DECELLULARIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DONOR CARDIOMYOCYTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DONOR STROMAL CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIOMYOCYTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STROMAL CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BOVINE CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PORCINE CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 107. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2030 (USD MILLION)
TABLE 109. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2030 (USD MILLION)
TABLE 110. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 111. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2030 (USD MILLION)
TABLE 112. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2030 (USD MILLION)
TABLE 114. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2030 (USD MILLION)
TABLE 115. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2030 (USD MILLION)
TABLE 116. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 118. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2030 (USD MILLION)
TABLE 119. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 120. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 122. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
TABLE 123. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 124. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2030 (USD MILLION)
TABLE 125. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2030 (USD MILLION)
TABLE 127. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2030 (USD MILLION)
TABLE 128. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 129. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2030 (USD MILLION)
TABLE 130. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2030 (USD MILLION)
TABLE 132. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2030 (USD MILLION)
TABLE 133. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2030 (USD MILLION)
TABLE 134. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 136. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2030 (USD MILLION)
TABLE 137. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 138. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 140. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
TABLE 141. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 142. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2030 (USD MILLION)
TABLE 216. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2030 (USD MILLION)
TABLE 218. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2030 (USD MILLION)
TABLE 219. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 220. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2030 (USD MILLION)
TABLE 221. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2030 (USD MILLION)
TABLE 223. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2030 (USD MILLION)
TABLE 224. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2030 (USD MILLION)
TABLE 225. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 227. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2030 (USD MILLION)
TABLE 228. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 229. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 231. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
TABLE 232. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 233. GERMANY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2030 (USD MILLION)
TABLE 234. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2030 (USD MILLION)
TABLE 236. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2030 (USD MILLION)
TABLE 237. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 238. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2030 (USD MILLION)
TABLE 239. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2030 (USD MILLION)
TABLE 241. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2030 (USD MILLION)
TABLE 242. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2030 (USD MILLION)
TABLE 243. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 245. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2030 (USD MILLION)
TABLE 246. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 247. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 249. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
TABLE 250. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 251. FRANCE CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2030 (USD MILLION)
TABLE 270. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2030 (USD MILLION)
TABLE 272. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2030 (USD MILLION)
TABLE 273. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 274. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2030 (USD MILLION)
TABLE 275. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2030 (USD MILLION)
TABLE 277. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2030 (USD MILLION)
TABLE 278. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2030 (USD MILLION)
TABLE 279. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 281. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2030 (USD MILLION)
TABLE 282. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 283. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 285. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
TABLE 286. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 287. ITALY CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2030 (USD MILLION)
TABLE 288. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2030 (USD MILLION)
TABLE 290. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2030 (USD MILLION)
TABLE 291. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 292. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2030 (USD MILLION)
TABLE 293. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2030 (USD MILLION)
TABLE 295. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2030 (USD MILLION)
TABLE 296. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2030 (USD MILLION)
TABLE 297. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 299. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2030 (USD MILLION)
TABLE 300. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 301. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 303. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2030 (USD MILLION)
TABLE 304. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2030 (USD MILLION)
TABLE 305. SPAIN CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2030 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2030 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES CARDIAC TISSUE ENGINEERI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cardiac Tissue Engineering market report include:
  • Organovo Holdings, Inc.
  • Tara Biosystems, Inc.
  • InSphero AG
  • Ncardia B.V.
  • NovoHeart, Inc.
  • BioCardia, Inc.
  • BICO Group AB
  • Matricelf, Inc.
  • XylyxBio LLC
  • AxoSim, Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 11.37 Billion
Forecasted Market Value ( USD ) by 2030 $ 17.18 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cardiac Tissue Engineering Market Size, Share & Trends by Material (Scaffold, Stem Cells), Product (Heart Valve, Vascular Grafts), Applications (MI,Congenital Heart Disease), End-user (Hospitals & Clinics, Academics & Research Institutes) - Global Forecast to 2029 - Product Image

Cardiac Tissue Engineering Market Size, Share & Trends by Material (Scaffold, Stem Cells), Product (Heart Valve, Vascular Grafts), Applications (MI,Congenital Heart Disease), End-user (Hospitals & Clinics, Academics & Research Institutes) - Global Forecast to 2029

  • Report
  • 337 Pages
  • Global
From
Cardiac Tissue Engineering Global Market Report 2025 - Product Image

Cardiac Tissue Engineering Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Tissue Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Tissue Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Tissue Engineering Market Report 2025 - Product Image

Tissue Engineering Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Tissue Engineering Market by Product Type, Technology, Material, Application, End User - Global Forecast to 2030 - Product Image

Tissue Engineering Market by Product Type, Technology, Material, Application, End User - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.